While the US leads in early-phase obesity trials and investment, the country also faces challenges in disease burden, trial ...

A systematic review and subsequent expert review gave comprehensive insight into prognostic factors for patients receiving ...

The meta-analysis of 9 studies showed high sensitivity with slightly lower specificity with the less-invasive option for ...

Despite advances in diabetes care, new research reveals persistent economic disadvantages for middle-aged adults living with ...

Pieter Sonneveld, MD, PhD, professor of hematology and chair of the Erasmus MC Cancer Institute in Rotterdam, Netherlands, ...

Study findings show ChatGPT-4o provides accurate, complete, and trustworthy responses to patient-generated colorectal cancer ...

Facility-level disparities in adopting minimally invasive interval debulking surgery for ovarian cancer highlight urgent ...

The FDA approved retifanlimab (Zynyz; Incyte) as the first and only first-line treatment for advanced anal cancer, supported ...

The new executive order contains multiple provisions if pharmaceutical companies do not offer "most-favored nation" pricing ...

A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often ...

Late-breaking findings on pulmonology, critical care, and sleep medicine will be presented at the American Thoracic Society ...

CK Wang, MD, chief medical officer of COTA, highlights how a lack of screening tools and declining ob-gyn pipeline can compound historical disparities seen in Black women's access to care.